EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Med Sci (Paris), 27 10 (2011) 850-858 Article references

Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy

Jingjing Su, Yiting Fu, Zitong Cui, Zain Abidin, Jingsong Yuan, Xinmiao Zhang, Runmin Li and Chunzhen Zhao
Frontiers in Pharmacology 14 (2024)
https://doi.org/10.3389/fphar.2023.1349081

Mélanome métastatique, immunothérapie et survie à long terme : où en sommes-nous ?

Caroline Robert
Bulletin de l'Académie Nationale de Médecine 207 (6) 749 (2023)
https://doi.org/10.1016/j.banm.2023.03.020

DDTC-Cu(I) Based Metal-organic Framework (MOF) for Targeted Melanoma Therapy by Inducing SLC7A11/GPX4-mediated Ferroptosis

Chan Li, Sheng Zhou, Chuncheng Chen, Lijun Zhu, Shijie Li, Zhuoyue Song, Jian Liang, Chunzhi Tang, Nenggui Xu, Tao Liu and Shihui Liu
Colloids and Surfaces B: Biointerfaces 113253 (2023)
https://doi.org/10.1016/j.colsurfb.2023.113253

Development of a mechanism of action-reflective, dual target cell-based reporter bioassay for a bispecific monoclonal antibody targeting human CTLA-4 and PD-1

Weimin Chen, Madhu Pandey, Hong Sun, Andrea Rolong, Mingyan Cao, Dengfeng Liu, Jihong Wang, Lingmin Zeng, Alan Hunter and Shihua Lin
mAbs 13 (1) (2021)
https://doi.org/10.1080/19420862.2021.1914359

Pertinence des inhibiteurs des points de contrôle immunitaire chez les patients atteints de maladie auto-immune ou inflammatoire

François-Xavier Danlos and Olivier Lambotte
médecine/sciences 34 (6-7) 516 (2018)
https://doi.org/10.1051/medsci/20183406007

Mélanome — Thérapeutique par les médications : anticorps anti-CTLA-4 et anti-PD1

Caroline Robert and Christina Mateus
Bulletin de l'Académie Nationale de Médecine 198 (2) 297 (2014)
https://doi.org/10.1016/S0001-4079(19)31343-3

Rôle de CTLA-4 dans la cosignalisation négative du système immunitaire

Daniel Olive, Suong le Thi, Luc Xerri, Ivan Hirsch and Jacques A. Nunès
médecine/sciences 27 (10) 842 (2011)
https://doi.org/10.1051/medsci/20112710012